Tag: Prescription Drugs
Most of the Effect of Paroxetine for Treating Hot Flashes May Be Placebo Effect
Authors say mean treatment effect for hot flash frequency may only be 21 percent
Concizumab May Be Effective Prophylaxis for Hemophilia A or B With Inhibitors
Overall median annualized bleeding rate was 0 with concizumab
Rates of Tx Retention for Rifaximin Low Despite Benefits for Hepatic Encephalopathy
Lower treatment retention rates seen with 30-day, out-of-pocket costs ≥$150
Heart, Diabetes, Cancer Drugs on List for Medicare Price Negotiations, White House Says
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations
Most Immunosuppressive Drugs Not Linked to Risk for Cancer
No associations seen for TNF inhibitor, antimetabolite, calcineurin inhibitor, or alkylating agent classes with cancer
USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
Considerable net benefit seen for use of effective antiretroviral therapy for reducing risk for HIV acquisition
Tardive Dyskinesia Has Considerable Impact on Multiple Domains
Considerable impact scores reported in physical, psychological, social domains; professional lives also affected
Dupilumab Treatment Beneficial for Sleep in Atopic Dermatitis
12 weeks of treatment also yields benefits in peak pruritus, change in SCORing Atopic Dermatitis
Budesonide Yields Durable Reduction in eGFR for IgA Nephropathy
Clinically relevant reduction in eGFR seen over two years with targeted release formulation of budesonide
Eligibility Limited for Anti-β Amyloid mAbs in Seniors With MCI
Few older adults with MCI or mild dementia were eligible for lecanemab, aducanumab after applying clinical trial criteria
